Uncoupling of astrogliosis from epileptogenesis in adenosine kinase (ADK) transgenic mice.
The astrocytic enzyme adenosine kinase (ADK) is a key negative regulator of the brain's endogenous anticonvulsant adenosine. Astrogliosis with concomitant upregulation of ADK is part of the epileptogenic cascade and contributes to seizure generation. To molecularly dissect the respective roles of astrogliosis and ADK-expression for seizure generation, we used a transgenic approach to uncouple ADK-expression from astrogliosis: in Adk-tg mice the endogenous Adk-gene was deleted and replaced by a ubiquitously expressed Adk-transgene with novel ectopic expression in pyramidal neurons, resulting in spontaneous seizures. Here, we followed a unique approach to selectively injure the CA3 of these Adk-tg mice. Using this strategy, we had the opportunity to study astrogliosis and epileptogenesis in the absence of the endogenous astrocytic Adk-gene. After triggering epileptogenesis we demonstrate astrogliosis without upregulation of ADK, but lack of seizures, whereas matching wild-type animals developed astrogliosis with upregulation of ADK and spontaneous recurrent seizures. By uncoupling ADK-expression from astrogliosis, we demonstrate that global expression levels of ADK rather than astrogliosis per se contribute to seizure generation.
Li
Tianfu
T
R. S. Dow Neurobiology Laboratories, Portland, OR 97232, USA.
Lan
Jing-Quan
JQ
Boison
Detlev
D
D000248:Adenosine Kinase / Q000172:deficiency / Q000235:genetics / Q000378:metabolism*; D000818:Animals; D001253:Astrocytes / Q000201:enzymology; D001921:Brain / Q000201:enzymology; D016923:Cell Death; D002908:Chronic Disease; D004827:Epilepsy / Q000201:enzymology / Q000209:etiology*; D005911:Gliosis / Q000150:complications* / Q000201:enzymology; D007608:Kainic Acid; D008297:Male; D051379:Mice; D018345:Mice, Knockout; D008822:Mice, Transgenic; D017966:Pyramidal Cells / Q000201:enzymology; D012008:Recurrence; D012640:Seizures / Q000139:chemically induced / Q000209:etiology / Q000503:physiopathology / Q000517:prevention & control; D012720:Severity of Illness Index; D013226:Status Epilepticus / Q000150:complications / Q000503:physiopathology; D013997:Time Factors; D014018:Tissue Distribution; D019076:Transgenes; D015854:Up-Regulation
D000248:Adenosine Kinase; D007608:Kainic Acid
J Neurosci. 2004 Jan 21;24(3):692-701
14736855
Prog Neurobiol. 2008 Mar;84(3):249-62
18249058
Neurobiol Dis. 2008 Jan;29(1):142-60
17931873
Epilepsia. 2008 Oct;49(10):1651-64
18503563
Epilepsy Behav. 2009 Jan;14 Suppl 1:16-25
18835369
J Cereb Blood Flow Metab. 2008 Jan;28(1):17-23
17457365
J Clin Invest. 2008 Feb;118(2):571-82
18172552
Exp Neurol. 2009 Sep;219(1):126-35
19460372
Science. 2005 Oct 7;310(5745):113-6
16210541
Neuroscience. 2006 Sep 29;142(1):125-37
16859834
Purinergic Signal. 2008 Dec;4(4):339-46
18568425
Epilepsy Curr. 2008 Mar-Apr;8(2):46-7
18330468
Glia. 2007 Jan 1;55(1):36-45
17004232
Eur J Neurosci. 2003 Aug;18(4):820-8
12925008
Eur J Pharmacol. 2008 Oct 31;596(1-3):6-13
18727925
Neuron Glia Biol. 2007 Nov;3(4):353-66
18634566
Nat Med. 2005 Sep;11(9):973-81
16116433
J Neurosci. 2008 Mar 26;28(13):3264-76
18367594
Brain. 2005 Oct;128(Pt 10):2383-95
15930047
Physiol Rev. 2006 Jul;86(3):1009-31
16816144
Cell Mol Life Sci. 2008 Sep;65(18):2875-96
18560757
Brain. 2007 May;130(Pt 5):1276-88
17472985
J Cereb Blood Flow Metab. 2007 Jan;27(1):1-5
16685255
Trends Mol Med. 2007 Feb;13(2):54-63
17207662
Nat Neurosci. 2007 Nov;10(11):1369-76
17965657
J Clin Invest. 2004 Apr;113(7):1059-68
15057313
Trends Pharmacol Sci. 2006 Dec;27(12):652-8
17056128
Neurodegener Dis. 2007;4(1):28-33
17429216
Proc Natl Acad Sci U S A. 2002 May 14;99(10):6985-90
11997462
Neuron. 2008 Apr 24;58(2):168-78
18439402